AACR centennial series: the biology of cancer metastasis: historical perspective.
暂无分享,去创建一个
[1] A. Silvani,et al. CXCL12, CXCR4 and CXCR7 expression in brain metastases , 2009, Cancer biology & therapy.
[2] A. Barabasi,et al. Cancer metastasis networks and the prediction of progression patterns , 2009, British Journal of Cancer.
[3] Massimo Cristofanilli,et al. A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer. , 2009, The Journal of surgical research.
[4] J. Talmadge,et al. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. , 2009, International immunopharmacology.
[5] R. Virchow. As Based upon Physiological and Pathological Histology , 2009 .
[6] A. Varki,et al. Molecular basis of metastasis. , 2009, The New England journal of medicine.
[7] D. Noonan,et al. Prediction of breast cancer metastasis by genomic profiling: where do we stand? , 2009, Clinical & Experimental Metastasis.
[8] B. Rini,et al. Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients , 2009, Clinical Cancer Research.
[9] Ugo Del Monte,et al. Does the cell number 10(9) still really fit one gram of tumor tissue , 2009 .
[10] L. Bolund,et al. Estimation of tumor heterogeneity using CGH array data , 2009, BMC Bioinformatics.
[11] B. Rini,et al. Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients , 2008, Clinical Cancer Research.
[12] J. Harbour,et al. Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling , 2008, Melanoma research.
[13] Martin A. Nowak,et al. Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.
[14] G. Mundy. The premetastatic niche , 2008 .
[15] Lisa M. Coussens,et al. Immune cells as mediators of solid tumor metastasis , 2008, Cancer and Metastasis Reviews.
[16] A. Dimmler,et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. , 2008, Cancer research.
[17] W. Bremner,et al. Advances in male contraception. , 2008, Endocrine reviews.
[18] D. Nolan,et al. Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis , 2008, Science.
[19] W. Gerald,et al. Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.
[20] C. Heeschen,et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.
[21] D. Tarin,et al. Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications , 2007, Molecular oncology.
[22] K. Coombes,et al. Zonal heterogeneity for gene expression in human pancreatic carcinoma. , 2007, Cancer research.
[23] Aleksandar Dakic,et al. Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.
[24] S. Rafii,et al. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. , 2007, Trends in immunology.
[25] I. Fidler,et al. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. , 2007, Endocrine reviews.
[26] I. Fidler,et al. Murine models to evaluate novel and conventional therapeutic strategies for cancer. , 2007, The American journal of pathology.
[27] A. Dupuy,et al. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. , 2007, Journal of the National Cancer Institute.
[28] P. Kearns,et al. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. , 2007, Blood.
[29] Anne E Carpenter,et al. The Spemann organizer gene, Goosecoid, promotes tumor metastasis , 2006, Proceedings of the National Academy of Sciences.
[30] S. Rafii,et al. Preparing the "soil": the premetastatic niche. , 2006, Cancer research.
[31] Hong Zhang,et al. Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas , 2006, Molecular Cancer.
[32] Igor Jurisica,et al. Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity , 2006, Clinical Cancer Research.
[33] Ingo Fricke,et al. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. , 2006, Cancer research.
[34] D. Tarin,et al. Tumor–stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis , 2006, International journal of cancer.
[35] Gabriel Capellà,et al. Genetic instability and divergence of clonal populations in colon cancer cells in vitro , 2006, Journal of Cell Science.
[36] Alberto Mantovani,et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.
[37] K. Hunter,et al. Host genetics influence tumour metastasis , 2006, Nature Reviews Cancer.
[38] J. Thiery,et al. Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.
[39] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[40] Liang Cheng,et al. Clonal origin of lymph node metastases in bladder carcinoma , 2005, Cancer.
[41] Thomas Kirchner,et al. Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.
[42] C. Lewis,et al. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. , 2005, The American journal of pathology.
[43] J. Talmadge,et al. Hematopoietic progenitor cell mobilization in mice by sustained delivery of granulocyte colony-stimulating factor. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[44] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[45] D. Tarin,et al. The fallacy of epithelial mesenchymal transition in neoplasia. , 2005, Cancer research.
[46] D. Tarin,et al. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? , 2005, Cancer research.
[47] D. Tarin,et al. Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. , 2005, The American journal of pathology.
[48] Silvia Benvenuti,et al. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. , 2005, The Lancet. Oncology.
[49] D. Gabrilovich,et al. STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion1 , 2005, The Journal of Immunology.
[50] L. Trümper,et al. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. , 2004, Carcinogenesis.
[51] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[52] E. Ruoslahti,et al. Vascular zip codes in angiogenesis and metastasis. , 2004, Biochemical Society transactions.
[53] Annuska M Glas,et al. Gene expression profiles of primary breast tumors maintained in distant metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[54] Michael F. Clarke,et al. Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.
[55] G. Dontu,et al. Stem cells in normal breast development and breast cancer , 2003, Cell proliferation.
[56] S. Evans,et al. Tumor microvasculature as a barrier to antitumor immunity , 2003, Cancer Immunology, Immunotherapy.
[57] D Hölzel,et al. The process of metastasisation for breast cancer. , 2003, European journal of cancer.
[58] Ed Roos,et al. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. , 2003, Cancer research.
[59] P. Gosling. DORLAND’S ILLUSTRATED MEDICAL DICTIONARY , 2003, Australasian Chiropractic & Osteopathy.
[60] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[61] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[62] G. Dranoff. GM-CSF-secreting melanoma vaccines , 2003, Oncogene.
[63] I. Fidler,et al. Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population , 2003, Nature Genetics.
[64] I. Fidler,et al. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. , 2003, Journal of the National Cancer Institute.
[65] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[66] I. Fidler,et al. The organ microenvironment and cancer metastasis. , 2002, Differentiation; research in biological diversity.
[67] Birgit Luber,et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. , 2002, The American journal of pathology.
[68] Toru Watanabe,et al. Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma. , 2002, Anticancer research.
[69] N. Stoecklein,et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer , 2002, The Lancet.
[70] D. Larsimont,et al. Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[71] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[72] I. Fidler,et al. Critical determinants of metastasis. , 2002, Seminars in cancer biology.
[73] R. DePinho,et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. , 2002, Cancer cell.
[74] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[75] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[76] Andrew V. Nguyen,et al. Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.
[77] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[78] Nicholas R. English,et al. Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.
[79] R. Ronca,et al. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. , 2000, Blood.
[80] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[81] D. Carbone,et al. Clinical significance of defective dendritic cell differentiation in cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[82] L. Ellis,et al. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. , 2000, The oncologist.
[83] A. G. Herreros,et al. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.
[84] D. Carbone,et al. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[85] T. Chao,et al. Metaplastic carcinomas of the breast , 1999, Journal of surgical oncology.
[86] A. Schäffer,et al. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization. , 1999, The American journal of pathology.
[87] M. Young,et al. Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers. , 1999, International journal of immunopharmacology.
[88] S. Tsujitani,et al. Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. , 1998, British Journal of Cancer.
[89] D. Carbone,et al. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. , 1998, Blood.
[90] S. Rosenberg,et al. Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. , 1998, Journal of immunology.
[91] L. Liotta,et al. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. , 1998, Trends in genetics : TIG.
[92] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[93] A. Kessinger,et al. GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression , 1997, Bone Marrow Transplantation.
[94] Y. Miyagi,et al. Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. , 1997, Cancer research.
[95] A. Schäffer,et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. , 1997, Cancer research.
[96] D. Carbone,et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.
[97] Mike Wilson,et al. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[98] Erkki Ruoslahti,et al. Organ targeting In vivo using phage display peptide libraries , 1996, Nature.
[99] M. Toi,et al. Quantitative analysis of vascular endothelial growth factor in primary breast cancer , 1996, Cancer.
[100] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[101] Roland Holland,et al. Age‐dependent growth rate of primary breast cancer , 1993, Cancer.
[102] Bengt Lundgren,et al. Breast carcinoma growth rate described by mammographic doubling time and S‐phase fraction. Correlations to clinical and histopathologic factors in a screened population , 1992, Cancer.
[103] J. Folkman,et al. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.
[104] M. Kaminski,et al. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[105] I. Fidler,et al. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. , 1990, Cancer research.
[106] J. Talmadge,et al. Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685. , 1990, Journal of autoimmunity.
[107] T. P. Pretlow,et al. Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression. , 1990, Cancer research.
[108] P. Sloan,et al. Spindle-cell carcinoma: a case report. , 1990, The British journal of oral & maxillofacial surgery.
[109] H. Norris,et al. Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. , 1989, Human pathology.
[110] S. Paget. The distribution of secondary growths in cancer of the breast. 1889. , 1989, Cancer metastasis reviews.
[111] H. Jd,et al. The management of patients with adenocarcinoma and poorly differentiated carcinoma of unknown primary site. , 1989 .
[112] G. Nicolson. Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. , 1988, Biochimica et biophysica acta.
[113] R. Kerbel,et al. Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. , 1988, Cancer research.
[114] R. Kerbel,et al. Genetic tagging of tumor cells with retrovirus vectors: clonal analysis of tumor growth and metastasis in vivo , 1988, Molecular and cellular biology.
[115] I. Fidler,et al. Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals. , 1988, Cancer research.
[116] G. Nicolson. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites , 1988, Cancer and Metastasis Reviews.
[117] I. Fidler,et al. Influence of organ microenvironment on pigmentation of a metastatic murine melanoma. , 1988, Cancer research.
[118] J E Talmadge,et al. Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.
[119] B. Zbar,et al. Tumor cells transfected with the neomycin resistance gene (neo) contain unique genetic markers useful for identification of tumor recurrence and metastasis. , 1987, Invasion & metastasis.
[120] K. Tanaka,et al. Evidence by cellular mosaicism for monoclonal metastasis of spontaneous mouse mammary tumors. , 1987, Journal of the National Cancer Institute.
[121] Michael Stoker,et al. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility , 1987, Nature.
[122] I. Fidler,et al. The biology of cancer metastasis and implications for therapy. , 1987, Current problems in surgery.
[123] A. Hackett,et al. MONOCLONAL MARKER THAT PREDICTS EARLY RECURRENCE OF BREAST CANCER , 1987, The Lancet.
[124] B. Zbar,et al. Clonality of pulmonary metastases from the bladder 6 subline of the B16 melanoma studied by southern hybridization. , 1987, Journal of the National Cancer Institute.
[125] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[126] J E Talmadge,et al. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. , 1986, Cancer research.
[127] I. Fidler,et al. Different deficiencies in the prevention of tumorigenic-low-metastatic murine K-1735b melanoma cells from producing metastases. , 1986, Journal of the National Cancer Institute.
[128] I. Fidler,et al. Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. , 1986, Cancer research.
[129] G. Nicolson,et al. Organ specificity of metastatic tumor colonization is related to organ‐selective growth properties of malignant cells , 1986, International journal of cancer.
[130] E. Hay,et al. Cytodifferentiation and tissue phenotype change during transformation of embryonic lens epithelium to mesenchyme-like cells in vitro. , 1986, Developmental biology.
[131] R. Carter. Principles of Metastasis , 1986, British Journal of Cancer.
[132] S. Gordon,et al. Biology of the Macrophage , 1986, Journal of Cell Science.
[133] H. Smith,et al. Monoclonal antibody that defines human myoepithelium. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[134] I. Fidler. Macrophages and metastasis--a biological approach to cancer therapy. , 1985, Cancer research.
[135] D. Welch,et al. Implications of tumor progression on clinical oncology , 1985, Clinical & Experimental Metastasis.
[136] I. Fidler,et al. Development and progression of karyotypic variability in melanoma K1735 following X-irradiation. , 1985, Cancer research.
[137] I. Fidler,et al. Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases. , 1984, Cancer research.
[138] D. Tarin,et al. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. , 1984, Cancer research.
[139] R. Steele,et al. A high macrophage content in human breast cancer is not associated with favourable prognostic factors , 1984, The British journal of surgery.
[140] V. Ling,et al. Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. , 1984, Science.
[141] I. Fidler,et al. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. , 1984, Journal of the National Cancer Institute.
[142] B. Geiger,et al. Motility and adhesive properties of high- and low-metastatic murine neoplastic cells. , 1984, Cancer research.
[143] S. Kottaridis,et al. Uncontrolled growth of tumour stromal fibroblasts in vitro. , 1983, Experimental cell biology.
[144] I. Fidler,et al. Lack of correlation between the progressive growth of spontaneous metastases and their content of infiltrating macrophages. , 1982, Journal of the Reticuloendothelial Society.
[145] R. Fischer,et al. Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer. , 1982, British Journal of Cancer.
[146] G Poste,et al. Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[147] I. Fidler,et al. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. , 1982, Journal of the National Cancer Institute.
[148] J E Talmadge,et al. Evidence for the clonal origin of spontaneous metastases. , 1982, Science.
[149] I. Fidler,et al. Cancer metastasis is selective or random depending on the parent tumour population , 1982, Nature.
[150] G. Nicolson,et al. Tumor metastasis is not due to adaptation of cells to a new organ environment. , 1982, Science.
[151] E. Mayhew,et al. Metastatic inefficiency in mice bearing B16 melanomas. , 1982, British Journal of Cancer.
[152] I. Fidler,et al. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[153] C. Bucana,et al. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. , 1981, Journal of the National Cancer Institute.
[154] I. Fidler,et al. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[155] I. Fidler,et al. Macrophage content of metastatic and nonmetastatic rodent neoplasms. , 1981, Journal of immunology.
[156] I. Fidler,et al. Activation of rat alveolar macrophages to the tumoricidal state in the presence of progressively growing pulmonary metastases. , 1981, Cancer research.
[157] E. M. Lawler,et al. Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene‐induced sarcomas , 1980, International journal of cancer.
[158] I. Fidler,et al. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. , 1980, Cancer research.
[159] I. Fidler,et al. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. , 1980, Cancer research.
[160] J. Talmadge,et al. Role of NK cells in tumour growth and metastasis in beige mice , 1980, Nature.
[161] D. Fournier,et al. Growth rate of 147 mammary carcinomas , 1980, Cancer.
[162] L. Liotta,et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.
[163] I. Fidler,et al. The pathogenesis of cancer metastasis , 1980, Nature.
[164] I. Hart. The selection and characterization of an invasive variant of the B16 melanoma. , 1979, The American journal of pathology.
[165] Kerbel Rs. Immunologic studies of membrane mutants of a highly metastatic murine tumor. , 1979 .
[166] I. Fidler,et al. Influence of immune status on the metastasis of three murine fibrosarcomas of different immunogenicities. , 1979, Cancer research.
[167] M. Kripke,et al. Speculations on the role of ultraviolet radiation in the development of malignant melanoma. , 1979, Journal of the National Cancer Institute.
[168] A. Mantovani,et al. Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity , 1978, International journal of cancer.
[169] G. Nicolson,et al. Selection and biologic properties of malignant variants of a murine lymphosarcoma. , 1978, Journal of the National Cancer Institute.
[170] G. Nicolson,et al. Specificity of arrest, survival, and growth of selected metastatic variant cell lines. , 1978, Cancer research.
[171] I. Fidler,et al. Tumor heterogeneity and the biology of cancer invasion and metastasis. , 1978, Cancer research.
[172] I. Fidler,et al. Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. , 1978, Cancer research.
[173] S. Shackney,et al. Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review. , 1978, Annals of internal medicine.
[174] E. Briles,et al. Isolation and metastatic properties of detachment variants of B16 melanoma cells. , 1978, Journal of the National Cancer Institute.
[175] I. Fidler,et al. Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.
[176] L. Liotta,et al. Degradation of basement membrane by murine tumor cells. , 1977, Journal of the National Cancer Institute.
[177] R. Kerbel,et al. An assessment of intratumor phagocytic and surface marker-bearing cells in a series of autochthonous and early passaged chemically induced murine sarcomas. , 1976, Journal of the National Cancer Institute.
[178] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[179] S. Eccles,et al. THE SIGNIFICANCE OF MACROPHAGES IN HUMAN AND EXPERIMENTAL TUMORS * , 1976, Annals of the New York Academy of Sciences.
[180] I. Fidler,et al. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. , 1976, Cancer research.
[181] M. S. Fisher,et al. Immunologic parameters of ultraviolet carcinogenesis. , 1976, Journal of the National Cancer Institute.
[182] G. Nicolson,et al. Organ specificity of blood-borne tumour metastasis determined by cell adhesion? , 1975, Nature.
[183] P. Gullino,et al. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. , 1975, Cancer research.
[184] S. Eccles,et al. Macrophage content of tumours in relation to metastatic spread and host immune reaction , 1974, Nature.
[185] B. Morson,et al. Evolution of cancer of the colon and rectum , 1974, Cancer.
[186] I. Fidler,et al. Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.
[187] B. Giovanella,et al. Metastases of Human Melanomas Transplanted in “Nude” Mice , 1973 .
[188] I. Fidler,et al. Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .
[189] B. Fisher,et al. The organ distribution of disseminated 51 Cr-labeled tumor cells. , 1967, Cancer research.
[190] B. Fisher,et al. The interrelationship of hematogenous and lymphatic tumor cell dissemination. , 1966, Surgery, gynecology & obstetrics.
[191] T. Gasic,et al. Removal of sialic acid from the cell coat in tumor cells and vascular endothelium, and its effects on metastasis. , 1962, Proceedings of the National Academy of Sciences of the United States of America.
[192] P. Nowell,et al. Differential growth of metastatic tumors in liver and lung; experiments with rabbit V2 carcinoma. , 1952, Cancer research.
[193] J. Buss,et al. Transpulmonary passage of tumor cell emboli. , 1952, Cancer research.
[194] D. R. Coman. Decreased Mutual Adhesiveness, a Property of Cells from Squamous Cell Carcinomas , 1944 .
[195] Neoplastic Diseases: A Treatise on Tumours , 1928, The Indian Medical Gazette.
[196] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[197] J. Cohnheim. Ueber Entzündung und Eiterung , 1867, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.
[198] S. Kasimir-Bauer. Circulating Tumor Cells as Markers for Cancer Risk Assessment and Treatment Monitoring , 2012, Molecular Diagnosis & Therapy.
[199] D. Peeper,et al. Metastasis mechanisms. , 2009, Biochimica et biophysica acta.
[200] Mark Shackleton,et al. Efficient tumour formation by single human melanoma cells , 2008 .
[201] Miriam K. Konkel,et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2008, Nature.
[202] J. Massagué,et al. Beyond tumorigenesis: cancer stem cells in metastasis , 2007, Cell Research.
[203] I. Fidler,et al. Growth in an organ microenvironment as a selective process in metastasis , 2005, Clinical & Experimental Metastasis.
[204] C. Brigati,et al. Tumors and inflammatory infiltrates: Friends or foes? , 2004, Clinical & Experimental Metastasis.
[205] K. Malmberg,et al. Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape? , 2004, Cancer immunology, immunotherapy : CII.
[206] I. Fidler,et al. Tumor cell antigenicity, host immunity, and cancer metastasis , 2004, Cancer Immunology, Immunotherapy.
[207] I. Bross,et al. The metastatic spread of myeloma and leukemias in men , 2004, Virchows Archiv A.
[208] I. Fidler,et al. The Biology of Melanoma Brain Metastasis , 2004, Cancer and Metastasis Reviews.
[209] N. Hanna. Role of natural killer cells in control of cancer metastasis , 2004, Cancer and Metastasis Reviews.
[210] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[211] Lurias,et al. MUTATIONS OF BACTERIA FROM VIRUS SENSITIVITY TO VIRUS RESISTANCE’-’ , 2003 .
[212] I. Macdonald,et al. Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.
[213] S. Goodison,et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[214] René Bernards,et al. A progression puzzle. , 2002, Nature.
[215] D. Carbone,et al. VEGF as a mediator of tumor-associated immunodeficiency , 2001, Immunologic research.
[216] D. Newgreen,et al. Epithelium-mesenchyme transition during neural crest development. , 1995, Acta anatomica.
[217] E. Hay. An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.
[218] B. S. Baker,et al. Dosage compensation in Drosophila. , 1994, Annual review of genetics.
[219] G. Opdenakker,et al. Chemotactic factors, passive invasion and metastasis of cancer cells. , 1992, Immunology today.
[220] M. Mareel,et al. Biology of cancer invasion and metastasis. , 1992, Acta oto-rhino-laryngologica Belgica.
[221] P. Nowell. Chromosomal and molecular clues to tumor progression. , 1989, Seminars in oncology.
[222] R. Virchow. Cellular pathology. As based upon physiological and pathological histology. Lecture XVI--Atheromatous affection of arteries. 1858. , 1989, Nutrition reviews.
[223] J. Folkman,et al. Angiogenic factors. , 1987, Science.
[224] I. Fidler,et al. Correlation between the in vitro interaction of tumor cells with an organ environment and metastatic behavior in vivo. , 1987, Invasion & metastasis.
[225] L. Liotta. Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.
[226] G. Poste,et al. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. , 1986, Cancer treatment reports.
[227] H. Strander. Interferon treatment of human neoplasia. , 1986 .
[228] S. Strober. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. , 1984, Annual review of immunology.
[229] G. Nicolson,et al. Cancer invasion and metastasis : biologic and therapeutic aspects , 1984 .
[230] J. Folkman. Angiogenesis: initiation and modulation. , 1983, Symposium on Fundamental Cancer Research.
[231] D. Witiak,et al. Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds. , 1982, Advances in pharmacology and chemotherapy.
[232] G. Poste,et al. On the genesis and regulation of cellular heterogeneity in malignant tumors. , 1982, Invasion & metastasis.
[233] I. Fidler,et al. In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes. , 1981, Journal of the National Cancer Institute.
[234] E. Grundmann,et al. Metastatic tumor growth , 1980 .
[235] R. Kerbel. Immunologic studies of membrane mutants of a highly metastatic murine tumor. , 1979, The American journal of pathology.
[236] E. Sugarbaker,et al. Cancer metastasis: a product of tumor-host interactions. , 1979, Current problems in cancer.
[237] I. Fidler. Biological behavior of malignant melanoma cells correlated to their survival in vivo. , 1975, Cancer research.
[238] P. Alexander,et al. The macrophage content of some human tumours. , 1975, Cancer letters.
[239] B. Giovanella,et al. Brief communication: metastases of human melanomas transplanted in "nude" mice. , 1973, Journal of the National Cancer Institute.
[240] I. J. Fidler. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine. , 1970, Journal of the National Cancer Institute.
[241] E. Klein. Immediate transformation of solid into ascites tumors; studies on a mammary carcinoma of an inbred mouse strain. , 1955, Experimental cell research.
[242] Makoto Takahashi. An experimental study of metastasis , 1915 .